Latest Insider Transactions at Inspire Md, Inc. (NSPR)
This section provides a real-time view of insider transactions for Inspire Md, Inc. (NSPR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of InspireMD, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of InspireMD, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
Michael Berman Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
61,249
+25.0%
|
$61,249
$1.38 P/Share
|
|
Jun 05
2024
|
Paul Stuka Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
87,500
+20.66%
|
$87,500
$1.38 P/Share
|
|
May 28
2024
|
Thomas J Kester Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
30,625
+8.57%
|
$30,625
$1.38 P/Share
|
|
May 28
2024
|
Gary S Roubin Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
30,625
+5.75%
|
$30,625
$1.38 P/Share
|
|
Jan 23
2024
|
Michael Berman Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,032
+11.12%
|
-
|
|
Jan 23
2024
|
Paul Stuka Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,548
+12.26%
|
-
|
|
Jan 23
2024
|
Marvin Slosman CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
563,499
+23.33%
|
-
|
|
Jan 23
2024
|
Gary S Roubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,032
+5.8%
|
-
|
|
Jan 23
2024
|
Craig Shore CFO and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
238,625
+21.34%
|
-
|
|
Jan 23
2024
|
Kathryn Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,032
+11.89%
|
-
|
|
Jan 23
2024
|
Andrea Tommasoli Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
238,625
+32.52%
|
-
|
|
Jan 23
2024
|
Shane Thomas Gleason Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
238,625
+31.69%
|
-
|
|
Jan 23
2024
|
Patrick Verta EVP Clinical/Medical Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
85,720
+27.28%
|
-
|
|
Jan 23
2024
|
Thomas J Kester Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,032
+8.93%
|
-
|
|
Jan 02
2024
|
Gary S Roubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,229
+0.73%
|
-
|
|
Jan 02
2024
|
Thomas J Kester Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,183
+1.18%
|
-
|
|
Jan 02
2024
|
Kathryn Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,661
+0.89%
|
-
|
|
Jan 02
2024
|
Michael Berman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,782
+1.83%
|
-
|
|
Nov 30
2023
|
Gary S Roubin Director |
BUY
Open market or private purchase
|
Direct |
50,000
+10.23%
|
$100,000
$2.53 P/Share
|
|
Oct 02
2023
|
Thomas J Kester Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,614
+0.98%
|
-
|
|
Oct 02
2023
|
Gary S Roubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,652
+0.68%
|
-
|
|
Oct 02
2023
|
Kathryn Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,364
+0.73%
|
-
|
|
Oct 02
2023
|
Michael Berman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,106
+1.54%
|
-
|
|
Aug 28
2023
|
Shane Thomas Gleason Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,290
+6.54%
|
-
|
|
Jul 01
2023
|
Gary S Roubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,445
+0.88%
|
-
|
|
Jul 01
2023
|
Kathryn Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,772
+0.96%
|
-
|
|
Jul 01
2023
|
Michael Berman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,351
+2.17%
|
-
|
|
Jul 01
2023
|
Thomas J Kester Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,396
+1.28%
|
-
|
|
May 17
2023
|
Kathryn Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
149,260
+45.17%
|
-
|
|
May 17
2023
|
Gary S Roubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
149,260
+28.05%
|
-
|
|
May 17
2023
|
Thomas J Kester Director |
BUY
Grant, award, or other acquisition
|
Direct |
149,260
+36.66%
|
-
|
|
May 17
2023
|
Andrea Tommasoli Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
179,080
+41.12%
|
-
|
|
May 17
2023
|
Michael Berman Director |
BUY
Grant, award, or other acquisition
|
Direct |
149,260
+43.73%
|
-
|
|
May 17
2023
|
Shane Thomas Gleason Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
256,450
+50.0%
|
-
|
|
May 17
2023
|
Paul Stuka Director |
BUY
Grant, award, or other acquisition
|
Direct |
225,680
+45.71%
|
-
|
|
May 17
2023
|
Craig Shore CFO and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
522,580
+44.9%
|
-
|
|
May 17
2023
|
Marvin Slosman CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
1,045,150
+44.78%
|
-
|
|
May 12
2023
|
Gary S Roubin Director |
BUY
Open market or private purchase
|
Direct |
61,249
+20.78%
|
$61,249
$1.63 P/Share
|
|
May 12
2023
|
Michael Berman Director |
BUY
Open market or private purchase
|
Indirect |
122,497
+50.0%
|
$122,497
$1.63 P/Share
|
|
May 12
2023
|
Thomas J Kester Director |
BUY
Open market or private purchase
|
Direct |
61,249
+36.06%
|
$61,249
$1.63 P/Share
|
|
May 12
2023
|
Paul Stuka Director |
BUY
Open market or private purchase
|
Indirect |
175,000
+41.32%
|
$175,000
$1.63 P/Share
|
|
Apr 01
2023
|
Gary S Roubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,102
+4.49%
|
-
|
|
Apr 01
2023
|
Kathryn Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,167
+11.54%
|
-
|
|
Apr 01
2023
|
Thomas J Kester Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,986
+14.43%
|
-
|
|
Apr 01
2023
|
Michael Berman Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,491
+18.14%
|
-
|
|
Aug 18
2022
|
Gary S Roubin Director |
BUY
Open market or private purchase
|
Direct |
35,500
+17.78%
|
$35,500
$1.91 P/Share
|
|
Dec 28
2021
|
Gary S Roubin Director |
BUY
Open market or private purchase
|
Direct |
16,393
+11.3%
|
$49,179
$3.08 P/Share
|
|
Dec 01
2021
|
Paul Stuka Director |
BUY
Open market or private purchase
|
Indirect |
12,037
+14.07%
|
$36,111
$3.51 P/Share
|
|
Nov 30
2021
|
Paul Stuka Director |
BUY
Open market or private purchase
|
Indirect |
18,372
+23.0%
|
$55,116
$3.55 P/Share
|
|
Nov 29
2021
|
Paul Stuka Director |
BUY
Open market or private purchase
|
Indirect |
3,177
+6.86%
|
$9,531
$3.55 P/Share
|